National Asset Management Inc. Invests $254,000 in Cooper Companies, Inc. (The) (COO)

National Asset Management Inc. acquired a new position in shares of Cooper Companies, Inc. (The) (NYSE:COO) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,267 shares of the medical device company’s stock, valued at approximately $254,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. AQR Capital Management LLC raised its position in Cooper Companies, Inc. (The) by 36.5% in the first quarter. AQR Capital Management LLC now owns 145,000 shares of the medical device company’s stock worth $28,984,000 after buying an additional 38,768 shares in the last quarter. Oppenheimer Asset Management Inc. acquired a new position in shares of Cooper Companies, Inc. (The) during the first quarter worth about $1,822,000. Oppenheimer & Co. Inc. raised its position in shares of Cooper Companies, Inc. (The) by 88.2% in the first quarter. Oppenheimer & Co. Inc. now owns 2,394 shares of the medical device company’s stock worth $479,000 after buying an additional 1,122 shares during the period. Schwab Charles Investment Management Inc. raised its position in shares of Cooper Companies, Inc. (The) by 7.5% in the first quarter. Schwab Charles Investment Management Inc. now owns 231,682 shares of the medical device company’s stock worth $46,311,000 after buying an additional 16,129 shares during the period. Finally, Champlain Investment Partners LLC raised its position in shares of Cooper Companies, Inc. (The) by 6.6% in the first quarter. Champlain Investment Partners LLC now owns 524,375 shares of the medical device company’s stock worth $104,817,000 after buying an additional 32,270 shares during the period. Institutional investors and hedge funds own 98.32% of the company’s stock.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Shares of Cooper Companies, Inc. (COO) traded up 0.28% during mid-day trading on Tuesday, hitting $242.79. The stock had a trading volume of 256,990 shares. The firm’s 50-day moving average price is $220.87 and its 200 day moving average price is $196.58. The stock has a market cap of $11.86 billion, a price-to-earnings ratio of 36.40 and a beta of 0.56. Cooper Companies, Inc. has a 12-month low of $158.73 and a 12-month high of $245.89.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its quarterly earnings data on Thursday, June 1st. The medical device company reported $2.50 EPS for the quarter, beating the Zacks’ consensus estimate of $2.25 by $0.25. The firm had revenue of $522.40 million for the quarter, compared to analyst estimates of $520.71 million. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The business’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same period last year, the company earned $2.05 EPS. Equities analysts forecast that Cooper Companies, Inc. will post $9.61 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This story was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this story on another domain, it was illegally copied and reposted in violation of US & international copyright law. The legal version of this story can be read at https://sportsperspectives.com/2017/06/20/national-asset-management-inc-invests-254000-in-cooper-companies-inc-the-coo.html.

A number of research analysts have issued reports on COO shares. Zacks Investment Research lowered Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a research report on Monday, March 6th. Jefferies Group LLC boosted their price target on Cooper Companies, Inc. (The) from $210.00 to $220.00 and gave the stock a “buy” rating in a research report on Friday, March 3rd. BMO Capital Markets reiterated a “buy” rating on shares of Cooper Companies, Inc. (The) in a research report on Friday, March 3rd. Piper Jaffray Companies reiterated an “overweight” rating and set a $220.00 price target on shares of Cooper Companies, Inc. (The) in a research report on Thursday, April 6th. Finally, J P Morgan Chase & Co reiterated a “neutral” rating and set a $206.00 price target (up previously from $200.00) on shares of Cooper Companies, Inc. (The) in a research report on Monday, June 5th. Two investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Cooper Companies, Inc. (The) currently has an average rating of “Buy” and an average price target of $230.44.

In other news, Director Stanley Md Zinberg sold 816 shares of the firm’s stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $243.14, for a total value of $198,402.24. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Paul L. Remmell sold 1,871 shares of the firm’s stock in a transaction on Friday, March 24th. The stock was sold at an average price of $201.40, for a total value of $376,819.40. Following the completion of the transaction, the chief executive officer now owns 4,276 shares in the company, valued at $861,186.40. The disclosure for this sale can be found here. Insiders sold a total of 59,292 shares of company stock worth $14,006,145 over the last quarter. Corporate insiders own 1.60% of the company’s stock.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply